Search details
1.
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
N Engl J Med
; 387(21): 1923-1934, 2022 Nov 24.
Article
in English
| MEDLINE | ID: mdl-36342113
2.
Effects of evolocumab in individuals with type 2 diabetes with and without atherogenic dyslipidemia: An analysis from BANTING and BERSON.
Cardiovasc Diabetol
; 20(1): 94, 2021 04 30.
Article
in English
| MEDLINE | ID: mdl-33941192
3.
Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.
N Engl J Med
; 376(16): 1527-1539, 2017 04 20.
Article
in English
| MEDLINE | ID: mdl-28304242
4.
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
N Engl J Med
; 377(12): 1119-1131, 2017 09 21.
Article
in English
| MEDLINE | ID: mdl-28845751
5.
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation.
Cardiovasc Diabetol
; 18(1): 71, 2019 06 04.
Article
in English
| MEDLINE | ID: mdl-31164165
6.
New evidence on the role of inflammation in CVD risk.
Curr Opin Cardiol
; 34(4): 418-423, 2019 07.
Article
in English
| MEDLINE | ID: mdl-31033505
7.
Randomised study of evolocumab in patients with type 2 diabetes and dyslipidaemia on background statin: Primary results of the BERSON clinical trial.
Diabetes Obes Metab
; 21(6): 1455-1463, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30821053
8.
Randomized study of evolocumab in patients with type 2 diabetes and dyslipidaemia on background statin: Pre-specified analysis of the Chinese population from the BERSON clinical trial.
Diabetes Obes Metab
; 21(6): 1464-1473, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30851062
9.
The Attitudes of Physicians Toward Guideline Recommendations for the Management of Dyslipidemia in Clinical Practice - The VIPFARMA ISCP Project.
Curr Probl Cardiol
; 48(1): 101434, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-36198357
10.
A randomized trial of rosuvastatin in the prevention of venous thromboembolism.
N Engl J Med
; 360(18): 1851-61, 2009 Apr 30.
Article
in English
| MEDLINE | ID: mdl-19329822
11.
Latin American Consensus on management of residual cardiometabolic risk. A consensus paper prepared by the Latin American Academy for the Study of Lipids and Cardiometabolic Risk (ALALIP) endorsed by the Inter-American Society of Cardiology (IASC), the International Atherosclerosis Society (IAS), and the Pan-American College of Endothelium (PACE).
Arch Cardiol Mex
; 92(1): 99-112, 2022 01 03.
Article
in English
| MEDLINE | ID: mdl-34187049
12.
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.
N Engl J Med
; 359(21): 2195-207, 2008 Nov 20.
Article
in English
| MEDLINE | ID: mdl-18997196
13.
Race, ethnicity, and the efficacy of rosuvastatin in primary prevention: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial.
Am Heart J
; 162(1): 106-14.e2, 2011 Jul.
Article
in English
| MEDLINE | ID: mdl-21742096
14.
Anti-inflammatory Treatment and Cardiovascular Outcomes: Results of Clinical Trials.
Eur Cardiol
; 16: e15, 2021 Feb.
Article
in English
| MEDLINE | ID: mdl-33976710
15.
Management of Dyslipidaemia in Real-world Clinical Practice: Rationale and Design of the VIPFARMA ISCP Project.
Eur Cardiol
; 16: e16, 2021 Feb.
Article
in English
| MEDLINE | ID: mdl-33995586
16.
Challenges in familial chylomicronemia syndrome diagnosis and management across Latin American countries: An expert panel discussion.
J Clin Lipidol
; 15(5): 620-624, 2021.
Article
in English
| MEDLINE | ID: mdl-34920815
17.
Considerations and Guidance for the Structure, Organisation, and Operation of Cardiometabolic Prevention Units: A Consensus Statement of the Inter-American Society of Cardiology.
Glob Heart
; 16(1): 27, 2021 04 27.
Article
in English
| MEDLINE | ID: mdl-34040940
18.
Results of an international crowdsourcing survey on the treatment of non-ST segment elevation ACS patients at high-bleeding risk undergoing percutaneous intervention.
Int J Cardiol
; 337: 1-8, 2021 08 15.
Article
in English
| MEDLINE | ID: mdl-34000356
19.
Ambulatory Patients with Cardiometabolic Disease and Without Evidence of COVID-19 During the Pandemic. The CorCOVID LATAM Study.
Glob Heart
; 16(1): 15, 2021 02 17.
Article
in English
| MEDLINE | ID: mdl-33833939
20.
Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.
Lancet
; 373(9670): 1175-82, 2009 Apr 04.
Article
in English
| MEDLINE | ID: mdl-19329177